Skip to main content
Caplight Logo









ProFoldBio

ProFoldBio

Private
Goleta, CaliforniaHealthcare & Life Scienceshttps://www.profoldbio.com/

Company Overview

ProFoldBio is a biotechnology company that provides a software platform using generative AI to accelerate the discovery and development of therapies for diseases such as Alzheimer's.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

protein stabilityprotein aggregationAI drug discoverydrug discovery platformsingle-molecule analysisgenerative biologybiologics developmentAI protein designAI-native biotechde-novo antibody designin-silico screeningcomputational drug discoverydrug discovery SaaSmonoclonal antibodiesformulation serviceslife sciences instrument

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProFoldBio Comparables

Compare ProFoldBio with similar companies based on industry and business-model similarity.

ProFoldBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoTemper Technologies
70%
Spectris plc
70%
Unchained Labs
68%

ProFoldBio Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

ProFoldBio Filings

Explore SEC and related filing metadata, where available.

ProFoldBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ProFoldBio's valuation, stock price, and market status.

Is ProFoldBio a public or private company?

ProFoldBio is a private company.

What is the current stock price of ProFoldBio?

ProFoldBio is a private company with no public stock price. No recent secondary market data is available.

How much is ProFoldBio worth (valuation)?

ProFoldBio's valuation is estimated at $1.8B based on funding round data.

Can I buy ProFoldBio stock?

ProFoldBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ProFoldBio's last funding round?

ProFoldBio's most recent funding round was M&A on May 21, 2024.

Who are the main investors in ProFoldBio?

Key investors in ProFoldBio include Ally Bridge Group, LYFE Capital, HongShan, 险峰K2VC, Lilly Asia Ventures.

Will ProFoldBio IPO soon?

No public IPO plans have been announced for ProFoldBio.

How can I track ProFoldBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ProFoldBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGoleta, California
Year Founded2025
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?